| Patient | Albert Einstein |
|---|---|
| Date of birth | 1956-03-14 |
| Identifiers | MRN HR-ET012-SYN; SSN (made up) 000-12-6650 |
| Document date | 2026-11-01 |
| Author | Clementine Ward, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing care for a known abdominal aortic aneurysm: duplex ultrasound, blood pressure, lipids, smoking, and emergency symptoms. Concerns: An abdominal operation for episodes of abdominal pain found a large swelling of the main artery in his abdomen, which was wrapped rather than repaired; he wants to know its size, how it will be watched, and when an operation would be advised; He has smoked a pipe since his youth and is willing to try to stop; His blood pressure has stayed above target on one medicine. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet by mouth each morning | Oral route | 2025-05-20 | active | S |
| Losartan 50 mg oral tablet, one tablet daily | One tablet by mouth each morning | Oral route | 2026-03-24 to 2026-04-21 | completed | S |
| Losartan 100 mg oral tablet, one tablet daily | One tablet by mouth each morning | Oral route | 2026-04-21 | active | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet by mouth each evening | Oral route | 2026-03-24 | active | S |
| Aspirin 81 mg delayed-release oral tablet, one tablet daily | One tablet by mouth daily with food | Oral route | 2026-04-21 | active | S |
| Nicotine 14 mg/24 hour transdermal patch, one patch daily | Apply one new patch each morning | Topical route | 2026-03-24 to 2026-07-14 | completed | S |
| Nicotine 7 mg/24 hour transdermal patch, one patch daily | Apply one new patch each morning | Topical route | 2026-07-14 to 2026-09-22 | completed | S |
| Nicotine 2 mg lozenge as needed for cravings | Dissolve one lozenge in the mouth for a craving, no more often than every 2 hours and no more than 20 a day | Oral route | 2026-03-24 to 2026-09-22 | completed | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| CT angiography of the abdominal aorta and iliac arteries: fusiform infrarenal aneurysm, maximum outer-wall diameter 5.2 cm, beginning 2.0 cm below the lowest renal artery and ending above the bifurcation; neck 2.2 cm wide with 30-degree angulation; moderate mural thrombus; calcified atheroma of the aorta and both common iliac arteries, which measure 1.3 cm; soft-tissue thickening along the front of the aneurysm consistent with the prior wrapping; no periaortic fluid; suprarenal aorta 2.4 cm | 2026-04-07 to 2026-04-07 | completed | S |
| Smoking cessation counseling (5 A's), about 15 minutes, with a quit date and nicotine replacement | 2026-03-24 to 2026-03-24 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2025-10-07 | High-dose influenza vaccine, 2025-2026 season | completed | S |
| 2026-08-25 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 2026-08-25 | Recombinant zoster vaccine, dose 1 of 2 | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1948 | Intermittent severe abdominal pain, at times with vomiting, worse toward the end of the year | D (CLM-0004) |
| December 31, 1948 | Exploratory laparotomy: a large abdominal aortic aneurysm was found; it could not be removed, and its front was wrapped in cellophane to provoke scarring; discharged about three weeks later | D (CLM-0005, CLM-0006) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| An abdominal operation for episodes of abdominal pain found a large swelling of the main artery in his abdomen, which was wrapped rather than repaired; he wants to know its size, how it will be watched, and when an operation would be advised | active | S |
| He has smoked a pipe since his youth and is willing to try to stop | active | S |
| His blood pressure has stayed above target on one medicine | active | S |
Most recent measures: Aorta Diameter by US 5 on 2026-06-02; Hemoglobin [Mass/volume] in Blood 14.2 on 2026-03-24; Leukocytes [#/volume] in Blood by Automated count 7.4 on 2026-03-24; Platelets [#/volume] in Blood by Automated count 232 on 2026-03-24; Sodium [Moles/volume] in Serum or Plasma 139 on 2026-07-14; Potassium [Moles/volume] in Serum or Plasma 4.7 on 2026-07-14; Creatinine [Mass/volume] in Serum or Plasma 1.1 on 2026-07-14; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 70 on 2026-07-14; Glucose [Mass/volume] in Serum or Plasma 98 on 2026-03-24; Calcium [Mass/volume] in Serum or Plasma 9.4 on 2026-03-24; Cholesterol [Mass/volume] in Serum or Plasma 132 on 2026-07-14; Cholesterol in HDL [Mass/volume] in Serum or Plasma 46 on 2026-07-14; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 62 on 2026-07-14; Triglyceride [Mass/volume] in Serum or Plasma 120 on 2026-07-14; Hemoglobin A1c/Hemoglobin.total in Blood 5.6 on 2026-03-24; Albumin/Creatinine [Mass Ratio] in Urine 14 on 2026-03-24; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 on 2026-03-24; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-08-25; Total score [AUDIT-C] 1 on 2026-08-25 [S]
Strengths and supports: Supports: a settled household, close colleagues, daily walks, and absorbing work [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Infrarenal abdominal aortic aneurysm, 5.0 cm by duplex ultrasound, found and wrapped at a prior exploratory laparotomy; under surveillance below the repair threshold | active | confirmed | I71.43 | S — Synthetic modern coding anchored to the documented aneurysm found and wrapped at his exploratory laparotomy; the diameter and all surveillance are synthetic. |
| Essential hypertension | active | confirmed | I10 | S — Synthetic risk factor in the modern frame; no historical blood pressure is documented in the cited sources. |
| Nicotine dependence, pipe tobacco | active | confirmed | F17.290 | S — Synthetic modern coding anchored to his documented pipe smoking. |
| Atherosclerosis of the abdominal aorta, with calcified atheroma on CT angiography | active | confirmed | I70.0 | S — Synthetic finding on the baseline CT angiography. |
| Acute low back strain after lifting, with aneurysm symptoms excluded; resolved | resolved | confirmed | S39.012A | S — Synthetic intercurrent illness at an unscheduled visit, chosen to teach how new back pain is assessed in a patient with a known aneurysm. It does not echo a documented illness. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-24 | Aorta Diameter by US | 5 | cm | <=3 cm | High | S |
| 2026-03-24 | Hemoglobin [Mass/volume] in Blood | 14.2 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-03-24 | Leukocytes [#/volume] in Blood by Automated count | 7.4 | 10*3/uL | 3.4-9.6 10*3/uL | Normal | S |
| 2026-03-24 | Platelets [#/volume] in Blood by Automated count | 232 | 10*3/uL | 135-317 10*3/uL | Normal | S |
| 2026-03-24 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-03-24 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-24 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-03-24 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 77 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-03-24 | Glucose [Mass/volume] in Serum or Plasma | 98 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-03-24 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-03-24 | Cholesterol [Mass/volume] in Serum or Plasma | 216 | mg/dL | <=200 mg/dL | High | S |
| 2026-03-24 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-03-24 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 142 | mg/dL | <=129 mg/dL | High | S |
| 2026-03-24 | Triglyceride [Mass/volume] in Serum or Plasma | 148 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-03-24 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.6 | % | <=5.6% | Normal | S |
| 2026-03-24 | Albumin/Creatinine [Mass Ratio] in Urine | 14 | mg/g{creat} | <=30 mg/g{creat} | Normal | S |
| 2026-03-24 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 7-55 U/L | Normal | S |
| 2026-04-21 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-04-21 | Potassium [Moles/volume] in Serum or Plasma | 4.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-04-21 | Creatinine [Mass/volume] in Serum or Plasma | 1.08 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-04-21 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 72 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-07-14 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-07-14 | Potassium [Moles/volume] in Serum or Plasma | 4.7 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-07-14 | Creatinine [Mass/volume] in Serum or Plasma | 1.1 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-07-14 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 70 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-07-14 | Cholesterol [Mass/volume] in Serum or Plasma | 132 | mg/dL | <=200 mg/dL | Normal | S |
| 2026-07-14 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 46 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-07-14 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 62 | mg/dL | <=129 mg/dL | Normal | S |
| 2026-07-14 | Triglyceride [Mass/volume] in Serum or Plasma | 120 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-09-22 | Aorta Diameter by US | 5.1 | cm | <=3 cm | High | S |
| 2026-06-02 | Aorta Diameter by US | 5 | cm | <=3 cm | High | S |
| 2026-08-25 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-08-25 | Total score [AUDIT-C] | 1 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-24 | Body height | 172 | cm | S |
| 2026-03-24 | Body weight | 79 | kg | S |
| 2026-03-24 | Body mass index (BMI) [Ratio] | 26.7 | kg/m2 | S |
| 2026-03-24 | Systolic blood pressure | 146 | mm[Hg] | S |
| 2026-03-24 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 2026-03-24 | Heart rate | 72 | /min | S |
| 2026-03-24 | Respiratory rate | 14 | /min | S |
| 2026-03-24 | Body temperature | 36.7 | Cel | S |
| 2026-03-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| 2026-04-21 | Body height | 172 | cm | S |
| 2026-04-21 | Body weight | 78.6 | kg | S |
| 2026-04-21 | Body mass index (BMI) [Ratio] | 26.6 | kg/m2 | S |
| 2026-04-21 | Systolic blood pressure | 136 | mm[Hg] | S |
| 2026-04-21 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 2026-04-21 | Heart rate | 70 | /min | S |
| 2026-04-21 | Respiratory rate | 14 | /min | S |
| 2026-04-21 | Body temperature | 36.6 | Cel | S |
| 2026-04-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-07-14 | Body height | 172 | cm | S |
| 2026-07-14 | Body weight | 79.4 | kg | S |
| 2026-07-14 | Body mass index (BMI) [Ratio] | 26.8 | kg/m2 | S |
| 2026-07-14 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2026-07-14 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-07-14 | Heart rate | 68 | /min | S |
| 2026-07-14 | Respiratory rate | 14 | /min | S |
| 2026-07-14 | Body temperature | 36.6 | Cel | S |
| 2026-07-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-09-22 | Body height | 172 | cm | S |
| 2026-09-22 | Body weight | 79.8 | kg | S |
| 2026-09-22 | Body mass index (BMI) [Ratio] | 27 | kg/m2 | S |
| 2026-09-22 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-09-22 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-09-22 | Heart rate | 66 | /min | S |
| 2026-09-22 | Respiratory rate | 14 | /min | S |
| 2026-09-22 | Body temperature | 36.6 | Cel | S |
| 2026-09-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-06-02 | Body height | 172 | cm | S |
| 2026-06-02 | Body weight | 79.2 | kg | S |
| 2026-06-02 | Body mass index (BMI) [Ratio] | 26.8 | kg/m2 | S |
| 2026-06-02 | Systolic blood pressure | 138 | mm[Hg] | S |
| 2026-06-02 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 2026-06-02 | Heart rate | 76 | /min | S |
| 2026-06-02 | Respiratory rate | 16 | /min | S |
| 2026-06-02 | Body temperature | 36.7 | Cel | S |
| 2026-06-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-08-25 | Body height | 172 | cm | S |
| 2026-08-25 | Body weight | 79.6 | kg | S |
| 2026-08-25 | Body mass index (BMI) [Ratio] | 26.9 | kg/m2 | S |
| 2026-08-25 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-08-25 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-08-25 | Heart rate | 66 | /min | S |
| 2026-08-25 | Respiratory rate | 14 | /min | S |
| 2026-08-25 | Body temperature | 36.6 | Cel | S |
| 2026-08-25 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-03-24 | Establishing care for a known abdominal aortic aneurysm: duplex ultrasound, blood pressure, lipids, smoking, and emergency symptoms | finished | S |
| 2026-04-21 | Four-week follow-up: CT angiography results, vascular surgery consultation, and a shared decision about repair thresholds | finished | S |
| 2026-07-14 | Three-month review: blood pressure, lipids on a statin, and smoking cessation | finished | S |
| 2026-09-22 | Six-month aneurysm surveillance with duplex ultrasound | finished | S |
| 2026-06-02 | Same-day sick visit for low back pain after lifting | finished | S |
| 2026-08-25 | Subsequent annual wellness visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Aneurysm imaging: duplex ultrasound today and CT angiography within two weeks for baseline anatomy; then duplex ultrasound every six months while the diameter is 5.0 to 5.4 cm, with CT if ultrasound views are poor | completed | GL-SVS-AAA-2018, GL-ACCAHA-AORTA-2022 | S |
| Vascular surgery consultation for a shared decision about surveillance, repair thresholds, and the choice between endovascular and open repair | completed | GL-SVS-AAA-2018, GL-ACCAHA-AORTA-2022 | S |
| Blood pressure below 130/80: add losartan 50 mg to amlodipine, home blood pressure readings twice daily for a week before each visit, and a metabolic panel two to four weeks after each change, then every six months | completed | GL-ACCAHA-AORTA-2022, GL-CMID-2026 | S |
| Atorvastatin 40 mg each evening, with a baseline ALT and a lipid panel four to twelve weeks after starting, then yearly | completed | GL-ACCAHA-AORTA-2022, GL-SVS-AAA-2018, GL-CMID-2026 | S |
| Tobacco cessation: the 5 A's at every visit, a quit date within a week, a 14 mg nicotine patch with 2 mg lozenges for cravings, stepping down over the following months, and the state quitline | completed | GL-ACCAHA-AORTA-2022, GL-SVS-AAA-2018, GL-USPSTF-TOB-2021 | S |
| Emergency plan: sudden severe abdominal, back, flank, or groin pain, fainting, or a tender pulsating lump means calling emergency services at once; carry an aneurysm wallet card; avoid fluoroquinolone antibiotics unless there is no alternative | completed | GL-SVS-AAA-2018, GL-ACCAHA-AORTA-2022 | S |
| Low-dose aspirin 81 mg daily for atheroma of the aorta, unless bleeding risk outweighs benefit | completed | GL-ACCAHA-AORTA-2022 | S |
| Shared decision on elective repair: repair advised at 5.5 cm by a consistent measurement, growth of 0.5 cm or more in six months, or symptoms from the aneurysm; endovascular repair favored on this anatomy and after a prior laparotomy with wrapping; his preferences reviewed at each scan | completed | GL-SVS-AAA-2018, GL-ACCAHA-AORTA-2022 | S |
| Monitor on the CMID hypertension and hyperlipidemia schedules: blood pressure and weight at every visit; metabolic panel every six months on losartan; lipids, HbA1c, and urine albumin-to-creatinine ratio yearly; baseline ECG; eye examination yearly; ankle-brachial index every two to three years | completed | GL-CMID-2026 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Baseline CT angiography and a vascular surgery consultation, with a documented shared decision about repair thresholds, by the four-week visit | 2026-04-21 | completed | CT angiography two weeks after the first visit; consultation and shared decision at the four-week visit | S |
| Blood pressure below 130/80 at the clinic and at home by the three-month visit | 2026-07-14 | completed | 126/76 mmHg in the clinic; home average 124/74 on amlodipine 5 mg and losartan 100 mg | S |
| LDL cholesterol at least 50 percent lower and below 70 mg/dL by the three-month visit | 2026-07-14 | completed | LDL 62 mg/dL on atorvastatin 40 mg, down 56 percent from 142 | S |
| Tobacco-free by the three-month visit and still at six months | 2026-09-22 | completed | No tobacco since the quit date a week after the first visit; nicotine replacement finished at six months | S |
| Repeat duplex ultrasound at six months and set the next interval by diameter | 2026-09-22 | completed | 5.1 cm, 0.1 cm more than at baseline; next scan in six months | S |